ESC Premium Access

Hot Line preventive strategies 1

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Hot Line
Date: 28 August 2016
Time: 16:30 - 18:00

Congress Session

12 presentations in this session

Optimal dual antiplatelet treatment (DAPT) duration following drug eluting stent with bioabsorbable polymer and abluminal coating, NIPPON study

Speaker: Professor M. Nakamura (Tokyo, JP)
Thumbnail

Optimal DAPT after DES - Discussant review.

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

Optimal DAPT after DES - Panel discussion.

Thumbnail

ANTARCTIC - Platelet function monitoring in elderly patients stented for an acute coronary syndrome

Speaker: Professor G. Montalescot (Paris, FR)
Thumbnail

ANTARCTIC - Discussant review.

Speaker: Professor S. Kristensen (Aarhus, DK)
Thumbnail

ANTARCTIC - Panel discussion.

Thumbnail

SAVE - The sleep apnea cardiovascular endpoints study results

Speaker: Professor D. McEvoy (Adelaide, AU)
Thumbnail

SAVE - Discussant review.

Speaker: Professor M. Cowie (London, GB)
Thumbnail

SAVE - Panel discussion.

Thumbnail

NACIAM Trial - The early use of N-acetylcysteine (NAC) with Glyceryl Trinitrate (GTN) in ST-segment Elevation Myocardial Infarction patients undergoing primary percutaneous coronary intervention

Speaker: Doctor S. Pasupathy (Adelaide, AU)
Thumbnail

8 speakers from this session

Professor Masato Nakamura

Toho University Ohashi Medical Center, Tokyo (Japan)
3 presentations
0 follower

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
47 presentations
2 followers

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Professor Steen Dalby Kristensen

Aarhus University Hospital, Aarhus (Denmark)
12 presentations
0 follower

Professor Doug McEvoy

Flinders Medical Centre and Flinders University, Adelaide (Australia)
1 presentation
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Doctor Sivabaskari Pasupathy

University of Adelaide, Adelaide (Australia)
3 presentations
0 follower

Professor Michel Ovize

Hospices Civils de Lyon and C.Bernard University, Lyon (France)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk